E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/3/2006 in the Prospect News Bank Loan Daily, Prospect News Distressed Debt Daily and Prospect News High Yield Daily.

S&P: MedCath unchanged

Standard & Poor's said its rating and outlook on MedCath Holdings Corp. (B+/stable) would not be affected by the company's filing of a 6 million share equity offering.

Of the 6 million total shares in the offering, 1.7 million are new shares offered by the company, 4.3 million will be offered by the company's two largest shareholders, MedCath 1998 LLC and Welsh, Carson, Anderson & Stowe VII, LP, the agency noted.

MedCath will use the proceeds of the new shares to repay debt, the agency added.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.